Govt Job for M.Pharm, M.Sc under Dept of Science and Technology

Jamia Hamdard was conceived as a seat of higher learning in Unani Medicine, Islamic Studies, Biosciences, Pharmacy, Nursing and other areas of knowledge by its founder as a means of fulfilling the objects of the wakf.

Over a period of last ten years, Jamia Hamdard has emerged as an outstanding institution of higher learning with distinct and focused academic programmes.

Graduate programme in Information Technology and Computer Applications and Post-graduate programmes in Information Technology, Computer Applications, Business Management, Physiotherapy and Occupational Therapy have been started in the last few years.

ADVERTISEMENT FOR JUNIOR RESEARCH FELLOW IN THE RESEARCH PROJECT SPONSORED BY SERB, DEPARTMENT OF SCIENCE & TECHNOLOGY, GOVT. OF INDIA

Tile of Project: “Cognitive remediation through Behavioral Reinforcement in Traumatic Brain Injury”

Essential qualifications :

M.Sc. Toxicology or M.Pharm. (Pharmacology) with first division
Qualified NET – JRF/LS examination of CSIR/UGC/ICMR for M.Sc. applicants or GATE for M.Pharm. applicants

Desirable : Experience in surgical models of rodents

Duration of appointment : Initially for a period of one year

Candidates fulfilling the eligibility criteria may submit the application along with recent CV and other relevant documents to the Principal Investigator, Prof. Suhel Parvez, Head, Department of Medical Elementology & Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi 110062 only by email (sparvez@jamiahamdard.ac.in).

Last date of receipt of applications is 19th April 2021.

Only short-listed candidates will be called for an interview.

Related Posts

Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

The ministry of health and family welfare has declared the Pharmacy Council of India’s (PCI) recently notified regulation on the pharmacist recruitment, promotion and services as ultra vires and does…

Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

NAIROBI/GENEVA— In an alarming development that underscores the accelerating global crisis of antimicrobial resistance, researchers have confirmed the detection of a rare, pan-drug resistant strain of the high-priority fungal pathogen…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications